Skip to main content

Carles Bravo Masgoret

Institutions of which they are part

Pneumology
Vall Hebron Institut de Recerca
Carles Bravo Masgoret

Projects

Valor diagnóstico de IFN-? ELISPOT en la infección pro citomegalovirus y la asociación de esta con el grado de inmunosupresión medida por la expresión genética de NFAT

IP: Victor Monforte Torres
Collaborators: Carles Bravo Masgoret, Alba Torija Recasens, Berta Saez Gimenez, Ibai Los Arcos Bertiz
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI18/00770
Duration: 01/01/2019 - 30/06/2023

ADN CIRCULANTE COMO BIOMARCADOR NO INVASIVO TRAS UN TRASPLANTE DE PULMÓN

IP: Antonio Román Broto
Collaborators: Juliana Esperalba Esquerra, Carles Bravo Masgoret, Vanessa Casares Rodríguez, Judith Sacanell Lacasa, Cristina Berastegui Garcia, Victoria Ruiz De Miguel, Manuel López Meseguer, Berta Saez Gimenez, Maria Martinez Martinez, Jordi Riera del Brío, Marina García García de Acilu
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01485
Duration: 01/01/2018 - 30/06/2022

EMITRON: Estudio del sistema MICA-NKG2D como factor inmunológico innato del riesgo de disfunción del trasplante de pulmón: un biomarcador potencialmente modificable

IP: Carles Bravo Masgoret
Collaborators: Antonio Román Broto
Funding agency: SOC.ESPAÑOLA NEUMOLOGIA CIRUGIA TORACICA
Funding: 12000
Reference: SEPAR-2013-01
Duration: 01/07/2013 - 31/08/2016

The ´EMITRON´ Study : Soluble MICA as a new Biomarker of Graft and Muscle Dysfunction in Lung Transplant recipients

IP: Carles Bravo Masgoret
Collaborators: -
Funding agency:
Funding:
Reference: PR(AG)364/2011
Duration: -

Related news

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

Related professionals

Juan Pedro Barret Nerín

Juan Pedro Barret Nerín

Read more
Nestor Gabriel Toapanta Gaibor

Nestor Gabriel Toapanta Gaibor

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Mercè Beltran Vilagrasa

Mercè Beltran Vilagrasa

Senior researcher
Read more
Joaquin Balsells Valls

Joaquin Balsells Valls

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.